Detalhe da pesquisa
1.
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience.
Br J Haematol
; 201(4): 663-672, 2023 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36762710
2.
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphoma.
Br J Haematol
; 198(1): 73-81, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35362096
3.
A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.
Mod Pathol
; 31(5): 732-743, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29327714
4.
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial.
Blood
; 124(26): 3870-9, 2014 Dec 18.
Artigo
Inglês
| MEDLINE | ID: mdl-25359988
5.
High efficacy of intensive immunochemotherapy for primary mediastinal B-cell lymphoma with prolonged follow up.
Sci Rep
; 12(1): 10551, 2022 06 22.
Artigo
Inglês
| MEDLINE | ID: mdl-35732790
6.
Prognostic Value of the Immunological Subtypes of Adolescent and Adult T-Cell Lymphoblastic Lymphoma; an Ultra-High-Risk Pro-T/CD2(-) Subtype.
Cancers (Basel)
; 13(8)2021 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33921074
7.
Efficacy of siltuximab in the treatment of idiopathic multicentric castleman disease, the first Polish, real-world experience with long-term observation.
Leuk Lymphoma
; 62(12): 3031-3034, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34159888